Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Synlait, A2 Milk appoint arbitrator for ongoing arbitration process

Published 12/21/2023, 03:56 PM
Updated 12/21/2023, 04:00 PM
© Reuters. FILE PHOTO: An A2 milk sign is seen at the third China International Import Expo (CIIE) in Shanghai, China November 6, 2020. REUTERS/Aly Song

(Reuters) - New Zealand's Synlait said on Friday an arbitrator has been appointed for the arbitration process with its second-largest stakeholder A2 Milk Co and both the companies are working on an agreement following cancellation of their exclusivity arrangements.

Both the companies agreed the arbitration process will include whether Synlait's obligation to procure a minimum annual volume of infant milk formula product, and certain other priority arrangements in favour of a2 Milk, will cease to apply.

In September, A2 Milk said it was terminating its exclusive rights to manufacture and supply a few of its infant milk formula products, claiming that Synlait's fiscal 2023 delivery performance fell short of what was necessary for it to keep these rights. Synlait disputed the claims.

Synlait on Friday forecast a lower half-year net profit after tax compared with the prior corresponding period. The company reported a net profit after tax of NZ$4.8 million for the first half of fiscal 2023.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.